Stratus Therapeutics

Cambridge, MA · Founded 2021 · Privately Held (backing)

Operator of a biotech company intended to treat patients with blood, bone marrow, immune, and metabolic diseases. Stratus Therapeutics is based in Cambridge, MA and was founded in 2021. Its last reported valuation was $210 million in Jan 2023. It has raised $184 million.

Last reported valuation
$210.0M
Oct 2026
Priced at
—
Total raised
$184.1M
Last round
—

Who backs Stratus Therapeutics?

13 investors
InvestorType
Alexandria Venture InvestmentsOther
OrbiMedGrowth equity
Cormorant Asset ManagementVenture capital
Monashee Investment ManagementHedge fund
Ridgeback CapitalVenture capital
Aisling CapitalVenture capital
ABI LAB—
Kyowa Kirin—
Mass General Brigham Ventures—
Northpond Ventures—
+ 3 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Stratus Therapeutics investors

13 investors are on record for Stratus Therapeutics, including Alexandria Venture Investments, OrbiMed, Cormorant Asset Management and Monashee Investment Management. By type, the record holds 3 venture capital firms, 1 hedge fund and 1 growth equity firm.

Free account
More of Stratus Therapeutics with a free account
  • ·The complete investor list: 13 names
  • ·Watch Stratus Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 13 firms already write checks for companies like Stratus Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View